Home/ Supplements/ Electrolytes/ Opti-50 Plus

Opti-50 Plus

product on market Powder IVL Institute For Vibrant Living Safety: 89/100
89/100

This product is generally safe

  • Niacin: 100mg is 2.9× the Tolerable Upper Intake Level (35mg)
  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 50% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The primary components listed are basic macronutrients and minerals, such as potassium and sodium, which support essential cellular functions. Research provides strong evidence for the necessity of these nutrients in a balanced diet. However, the overall evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 100mg is 2.9× the Tolerable Upper Intake Level (35mg)

Contains proprietary blend — exact ingredient amounts not disclosed

Label

Product Label

Label for Opti-50 Plus
Open Full PDF View on NIH DSLD →
Details

Label Data

12 Gram(s)
Serving Size
30
Servings
Other Combinations
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
24 {Calories} (1.2% DV)
Total Fat
Cholesterol
Sodium
Potassium
Total Carbohydrates
8.4 Gram(s) (2.8% DV)
Protein
Vitamin A
2500 IU (50% DV)
Vitamin C
150 mg (250% DV)
30 IU (100% DV)
1.3× RDA — within safe limits 179 studies (A:3, B:90)
3 mg (200% DV)
2.5× RDA — within safe limits 76 studies (A:0, B:33)
3 mg (176% DV)
2.3× RDA — within safe limits 13 studies (A:0, B:1)
100 mg (500% DV)
Exceeds UL by 2.9× (UL: 35 mg) 196 studies (A:5, B:63)
5 mg (250% DV)
3.8× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
400 mcg (100% DV)
Within RDA (1.0× RDA) 226 studies (A:10, B:105)
20 mcg (333% DV)
8.3× RDA — above typical dose 139 studies (A:1, B:44)
100 mcg (33% DV)
3.3× RDA — above typical dose 27 studies (A:0, B:11)
10 mg (100% DV)
2.0× RDA — within safe limits 2 studies — no high-quality reviews
Calcium
175 mg (17.5% DV)
80 mg (20% DV)
Within RDA (0.2× RDA) 316 studies (A:8, B:159)
15 mg (100% DV)
1.4× RDA — within safe limits 263 studies (A:6, B:134)
35 mcg (50% DV)
Within RDA (0.6× RDA) 173 studies (A:0, B:67)
6 mg (300% DV)
2.6× RDA — within safe limits 9 studies — no high-quality reviews
200 mcg (166% DV)
5.7× RDA — above typical dose 199 studies (A:1, B:55)
Market median: 80.0mg (20 products) 337 studies (A:8, B:183)
Proprietary Blend
3070 mg

Other Ingredients

Maltodextrin Guar Gum Citric Acid Maltrin Apple Juice Lemon and Natural Flavors Stevia leaf extract
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Mix approximately one (1) scoop in 6 to 8 ounces of juice or water.

Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN

Pregnant or lactating women should consult a healthcare professional prior to use.

Persons taking prescription medications and those with medical conditions should consult with a healthcare professional before beginning any new dietary supplement.

This product contains soy, wheat and barley.

Formulation Notes

This product contains soy, wheat and barley.

Additional Information

For maximum freshness, refrigerate after opening and use within 90 days.

MASTER GLUCOSE BALANCING FORMULA All Natural and pure as nature intended.

PLEASE RECYCLE

NOT TESTED ON ANIMALS

Metadata

Product Details

UPC / SKU8 93320 00256 0
DSLD Entry Date2013-08-23
Product TypeOther Combinations
FormPowder
DSLD ID24858
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.